Prevalence and Impact of Hyponatremia in Patients With Coronavirus Disease 2019 in New York City.
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Body Mass Index
COVID-19
/ epidemiology
Female
Hospital Mortality
/ trends
Humans
Hyponatremia
/ epidemiology
Interleukin-6
/ blood
Kaplan-Meier Estimate
Logistic Models
Male
Middle Aged
New York City
/ epidemiology
Pandemics
Patient Discharge
/ statistics & numerical data
Prevalence
Respiration, Artificial
/ statistics & numerical data
Retrospective Studies
Severity of Illness Index
Sex Factors
Young Adult
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
23
8
2020
medline:
22
12
2020
entrez:
23
8
2020
Statut:
ppublish
Résumé
Hyponatremia occurs in up to 30% of patients with pneumonia and is associated with increased morbidity and mortality. The prevalence of hyponatremia associated with coronavirus disease 2019 and the impact on outcome is unknown. We aimed to identify the prevalence, predictors, and impact on outcome of mild, moderate, and severe admission hyponatremia compared with normonatremia among coronavirus disease 2019 patients. Retrospective, multicenter, observational cohort study. Four New York City hospitals that are part of the same health network. Hospitalized, laboratory-confirmed adult coronavirus disease 2019 patients admitted between March 1, 2020, and May 13, 2020. None. Hyponatremia was categorized as mild (sodium: 130-134 mmol/L), moderate (sodium: 121-129 mmol/L), or severe (sodium: ≤ 120 mmol/L) versus normonatremia (135-145 mmol/L). The primary outcome was the association of increasing severity of hyponatremia and in-hospital mortality assessed using multivariable logistic regression analysis. Secondary outcomes included encephalopathy, acute renal failure, mechanical ventilation, and discharge home compared across sodium levels using Kruskal-Wallis and chi-square tests. In exploratory analysis, the association of sodium levels and interleukin-6 levels (which has been linked to nonosmotic release of vasopressin) was assessed. Among 4,645 patient encounters, hyponatremia (sodium < 135 mmol/L) occurred in 1,373 (30%) and 374 of 1,373 (27%) required invasive mechanical ventilation. Mild, moderate, and severe hyponatremia occurred in 1,032 (22%), 305 (7%), and 36 (1%) patients, respectively. Each level of worsening hyponatremia conferred 43% increased odds of in-hospital death after adjusting for age, gender, race, body mass index, past medical history, admission laboratory abnormalities, admission Sequential Organ Failure Assessment score, renal failure, encephalopathy, and mechanical ventilation (adjusted odds ratio, 1.43; 95% CI, 1.08-1.88; p = 0.012). Increasing severity of hyponatremia was associated with encephalopathy, mechanical ventilation, and decreased probability of discharge home (all p < 0.001). Higher interleukin-6 levels correlated with lower sodium levels (p = 0.017). Hyponatremia occurred in nearly a third of coronavirus disease 2019 patients, was an independent predictor of in-hospital mortality, and was associated with increased risk of encephalopathy and mechanical ventilation.
Identifiants
pubmed: 32826430
doi: 10.1097/CCM.0000000000004605
pmc: PMC7467047
mid: NIHMS1617605
pii: 00003246-202012000-00051
doi:
Substances chimiques
Interleukin-6
0
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1211-e1217Subventions
Organisme : NIA NIH HHS
ID : P30 AG066512
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS113844
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Nephron Physiol. 2011;118(2):45-51
pubmed: 21196778
Clin Endocrinol (Oxf). 2019 May;90(5):744-752
pubmed: 30657193
Respir Med. 2014 Nov;108(11):1696-705
pubmed: 25306251
Ann Clin Transl Neurol. 2020 Aug;7(8):1450-1452
pubmed: 32433817
Am J Respir Crit Care Med. 1997 Nov;156(5):1467-72
pubmed: 9372662
J Physiol. 1978 Dec;285:341-58
pubmed: 745091
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901
Intensive Care Med. 2014 Mar;40(3):320-31
pubmed: 24562549
Am J Med. 1957 Oct;23(4):529-42
pubmed: 13469824
Am J Physiol Endocrinol Metab. 2020 Jun 1;318(6):E882-E885
pubmed: 32396497
BMC Pulm Med. 2009 Jan 19;9:4
pubmed: 19152698
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Medicina (B Aires). 2006;66(6):505-11
pubmed: 17240620
Eur J Intern Med. 2020 May;75:44-49
pubmed: 31952985
Crit Care Med. 1998 Nov;26(11):1793-800
pubmed: 9824069
Clin Nephrol. 2020 Jan;93(1):42-46
pubmed: 31670650
Eur J Endocrinol. 2020 Jul;183(1):G9-G15
pubmed: 32380474
BMC Infect Dis. 2013 Dec 11;13:585
pubmed: 24330484
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
N Engl J Med. 2007 May 17;356(20):2064-72
pubmed: 17507705
BMC Pulm Med. 2008 Aug 18;8:16
pubmed: 18710521
Ann Trop Paediatr. 1992;12(4):455-62
pubmed: 1283678
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Am J Nephrol. 2007;27(2):184-90
pubmed: 17356253
J Hosp Med. 2012 Jul-Aug;7(6):464-9
pubmed: 22473687
Nature. 2020 Jul;583(7816):437-440
pubmed: 32434211
Eur J Endocrinol. 2016 Dec;175(6):499-507
pubmed: 27585594